NCT07651553

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2025-06-30Est. Completion: 2027-04-28

Enrollment target: 216 participants

Locations

the sixth affiliated hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Contact

Liang Kang, MDkangl@mail.sysu.edu.cn +8613602886833

Ling Shuang Luo, MDkangl@mail.sysu.edu.cn +8613751756175

Other microbiome trials you might be interested in

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationPhase 2Recruiting

Metastatic Colorectal CancerCRCKRAS/NRAS Mutation

The purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effe…

Phoenix, United StatesEst. completion Nov 2026

View Trial →

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsRecruiting

Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.